Daiichi Sankyo
Amanda Ulibarri Webb, PharmD, BCPS, currently serves as the Director of Field Medical Affairs - Oncology at Daiichi Sankyo, Inc., a position held since February 2018, following various roles including Associate Director for Medical Science Liaison and Commercial Training & Development. Prior experience includes serving as a Clinical Pharmacist PRN at John Peter Smith Hospital, Director of Global Health Science at The Medicines Company, and Clinical Pharmacist positions in bone marrow transplant and oncology, as well as abdominal solid organ transplant at Baylor Scott & White Health and Baylor University Medical Center. Amanda earned a Doctor of Pharmacy from Texas Tech University Health Sciences Center and a Bachelor of General Studies with a focus on Biology, Chemistry, and English from Texas Tech University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.